iShares Genomics Immunology and Healthcare ETF Rating $22.65 -0.54 (-2.33%) Closing price 04:10 PM EasternExtended Trading$22.64 -0.01 (-0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.68Holdings in IDNA have an aggregate rating of Moderate Buy based on 235 analyst ratings issued in the past year covering 17 companies (54.7% of the portfolio).IDNA Aggregate Price Target$22.65High Prediction$22.65Average Prediction$22.65Low Prediction$22.65Holdings in IDNA have an aggregate price target of $22.65 and a range of $22.65 to $22.65 covering 17 companies (54.7% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.82%INCYIncyte$83.10-3.6%4.7513 of 5 stars2.33$82.53 -0.7%18Positive NewsShort Interest ↓4.66%REGNRegeneron Pharmaceuticals$560.00-1.4%4.7604 of 5 stars2.82$817.67 46.0%28Positive NewsShort Interest ↑4.18%MRKMerck & Co., Inc.$82.87-2.7%4.9965 of 5 stars2.35$107.44 29.6%20Positive News4.09%ACLXArcellx$76.19-1.9%2.2235 of 5 stars3.13$114.31 50.0%15Positive News3.77%CELCCelcuity$54.91-4.4%1.4416 of 5 stars3.00$56.50 2.9%4Positive News3.72%BNTXBioNTech$96.74-7.3%2.5139 of 5 stars2.76$135.80 40.4%17Gap DownHigh Trading Volume3.70%RVMDRevolution Medicines$46.55+0.7%4.2282 of 5 stars3.07$73.67 58.3%15Trending NewsAnalyst ForecastAnalyst Revision3.53%MRNAModerna$23.51-7.4%4.4907 of 5 stars2.04$42.88 82.4%24Positive NewsHigh Trading Volume3.49%EXELExelixis$39.15+0.2%4.7039 of 5 stars2.52$44.06 12.5%23Positive News3.34%TWSTTwist Bioscience$25.31-1.2%3.978 of 5 stars2.73$49.40 95.2%11News Coverage3.04%BCRXBioCryst Pharmaceuticals$7.91-2.0%4.2643 of 5 stars2.90$16.70 111.1%10Positive News2.56%JANXJanux Therapeutics$24.05-4.3%2.4885 of 5 stars3.07$80.92 236.5%15News CoverageAnalyst Forecast2.50%NVAXNovavax$7.98-3.6%4.4804 of 5 stars2.13$14.29 79.0%8Positive News2.16%ABCLAbCellera Biologics$4.47-3.0%2.4296 of 5 stars3.00$8.00 79.0%61.93%GERNGeron$1.27-3.8%3.1384 of 5 stars2.29$3.79 198.1%7Positive News1.70%IMNMImmunome$9.21-4.9%2.1085 of 5 stars3.00$22.89 148.5%9High Trading Volume1.53%RIGLRigel Pharmaceuticals$37.96+0.4%2.0524 of 5 stars2.40$38.20 0.6%5News CoveragePositive NewsShort Interest ↓ This page (NYSEARCA:IDNA) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCollect Your $21K — Courtesy of Donald Trump 🇺🇸A small group of early investors have found a way to start collecting payouts as high as $21,307 — before the ...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDNA Stock Alerts